Tate & Lyle's innovative ingredients can help food and beverage manufacturers tackle global diabetes epidemic

| Filed in:

New glycaemic response white paper from Tate & Lyle explores the role food and beverage manufacturers can play in developing products that help consumers manage blood glucose while following dietary guidelines

Glycaemic response white paper email

London, UK, 14 November 2019: Tate & Lyle PLC (Tate & Lyle), a leading global provider of food and beverage ingredients and solutions, is proud to work with customers worldwide to improve the healthiness of the food supply. Diabetes affects over 425 million people globally (Source: International Diabetes Federation) and today’s World Diabetes Day provides food and beverage businesses with an opportunity to consider what more they can do to support global efforts to tackle Type II diabetes.

Given public health concerns surrounding the high incidence of diabetes and metabolic syndrome, managing blood glucose is very important. Tate & Lyle has published a white paper which explores the diabetes epidemic, dietary interventions and the role food and beverage manufacturers can play in developing products to help consumers manage blood glucose. It also looks at how Tate & Lyle’s innovative ingredients, such as fibres, rare sugars, and low and non-nutritive sweeteners, can help address glycaemic response in food and beverage products.

Dr. Kavita Karnik, VP Global Nutrition at Tate & Lyle, said:

"We believe people should be able to make healthy food and drink choices by having access to low calorie, low sugar and high fibre options. That's why we have a range of ingredients that food and beverage producers can use to make the products that, ultimately, could help prevent or manage incidences of Type II diabetes around the globe. We partner with our customers to help them not only achieve great tasting foods and beverages, but also to improve lives, and helping to prevent Type II diabetes with our ingredients is just one way we’re doing this."

Tate & Lyle’s range of fibres and sweeteners can help food and beverage manufacturers produce lower calorie, high fibre options for consumers that can help keep blood sugar at healthy levels, without compromising taste.

Tate & Lyle’s soluble fibre products are shown to significantly lower postprandial blood glucose and insulin levels. They include PROMITOR® Soluble Fibre and STA-LITE® Polydextrose soluble fibre. Our portfolio of non-nutritive sweeteners are low or zero calorie, but maintain the desired sweetness otherwise provided by sugar. They include DOLCIA PRIMA® Allulose, SPLENDA® Sucralose, Stevia Sweeteners and PUREFRUIT™ Monk Fruit Extract.

Learn more about how we partner with our customers to achieve food and beverage formulation goals, such as reducing sugar and calories.

# # #

Note to Editors

Media contact:

Miriam Wilkens, VP Global Communications, Tate & Lyle PLC, [email protected]

Learn more from our white paper on Glycaemic Response

About Tate & Lyle: 
Tate & Lyle PLC is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fibre fortification, our Food & Beverage Solutions business develops solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings. Our Primary Products business produces nutritive sweeteners, industrial starches used in paper and packaging, acidulants and products used for animal nutrition.

We have around 4,500 employees working in more than 60 locations across 30 countries. Tate & Lyle’s purpose is Improving Lives for Generations and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on TwitterLinkedin or Facebook.